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The state and development of the intestinal epithelium is vital for infant health, and increased
understanding in this area has been limited by an inability to directly assess epithelial cell biology in the
healthy newborn intestine. To that end, we have developed a novel, noninvasive, molecular approach that
utilizes next generation RNA sequencing on stool samples containing intact epithelial cells for the purpose
of quantifying intestinal gene expression. We then applied this technique to compare host gene expression
in healthy term and extremely preterm infants. Bioinformatic analyses demonstrate repeatable detection of
humanmRNAexpression, and network analysis shows immune cell function and inflammation pathways to
be up-regulated in preterm infants. This study provides incontrovertible evidence that whole-genome
sequencing of stool-derived RNA can be used to examine the neonatal host epithelial transcriptome in
infants, which opens up opportunities for sequential monitoring of gut gene expression in response to
dietary or therapeutic interventions.
G
rowth and maturation of the gastrointestinal tract occurs on a set developmental ontogeny1,2. Although
some aspects of intestinal development appear to be hardwired and do not emerge until a specific
gestational age3, others are influenced by dietary intake1 and microbial colonization4. Accordingly, the
early neonatal period is a critical phase for both intestinal digestive development as well as establishment
(colonization) of the intestinal microbiota5. Functional immaturity of the gut compromises nutrient absorption
and utilization in the preterm3. This digestive immaturity, coupled with immature mucosal barrier function,
immune response and inappropriate bacterial colonization, makes premature neonates particularly susceptible to
intestinal inflammation and injury and the development of necrotizing enterocolitis (NEC), a potentially lethal
bowel disorder3,6–8.
The intestine is lined by epithelial cells that process nutrients and provide the first line of defense against
pathogens. Because colonization of the intestine with non-pathogenic, or commensal, bacteria is vital for infant
health, it is important to understand how epithelial cells and the microbial ecosystem are modulated by diet and
disease9. Therefore, our on-going efforts are directed at understanding the regulation of neonatal development by
components present in human milk, as it is the gold standard for infant nutrition10–12. Advancing knowledge in
this area has been limited by an inability to directly assess epithelial cell biology in the healthy newborn intestine.
Previously, to that end, we developed non-invasive high throughput microarray techniques to examine intestinal
gene expression in stool samples11 and to probe the cross-talk between host gene expression and themicrobiota12.
This methodology has the advantage of using exfoliated cell mRNA directly isolated from feces, which contains
sloughed small intestinal and colon cells, and therefore does not require invasive procedures or discomfort to the
subject.
In this study, we applied our non-invasive methodology, which has been optimized in the term infant, to the
extremely preterm infant (24–30 weeks gestational age). With respect to neonatal health, it is well known that
extremely preterm infants are a vulnerable population whose intestinal and immune development is modulated
early in the postnatal period bymultiple environmental factors, such as medications, indigenousmicroorganisms
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in the intensive care unit, and limited enteral diet13. Using global
transcriptome RNA Sequencing (RNA-Seq) profiling, we compared
host transcript abundance and alternative splicing in healthy term
and extremely preterm infants. This novel application of RNA-Seq to
measure host gene expression has, for the first time, provided insight
into host responses to dietary and environmental influences in the
early neonatal period.
Results
Fecal samples were obtained from three term and three preterm
infants and enriched for host mRNA transcripts through poly A1
RNA selection. We also considered the effects of pooling by sequen-
cing a sample consisting of multiple term infants. Approximately
50 M reads were sequenced for each individual and 30 M reads for
the pooled sample, and on average 5075 human genes were detected
above an FPKM threshold of one despite 55–90% of the reads map-
ping to a representative set of microbial genomes (Supplementary
Table 1). Complementary analyses were conducted using ERCC
spike-in RNA controls, sample correlations, and qPCR in order to
validate the host mRNA transcript data.
In general, transcripts consisted of hundreds of reads that accu-
mulated in a narrow region in or close to the 39 UTR. A typical
example is RefSeq id NM_000482, representing apolipoprotein A-
IV (Supplementary Figure 1). Since bacterial RNA in stool is much
more abundant than human RNA14, the first objective was to ascer-
tain the efficacy of host poly A1 RNA enrichment, library prepara-
tion, and sequencing procedures. We note that poly A1 RNA
enrichment precludes the use of these data to probe microbiome
diversity or transcript levels due to the bias this procedure might
place on the microbial transcripts. ERCC spike-in controls added
at step A in Figure 1 were used to verify the integrity of sample
handling from steps A to B. The ERCC controls reflect a diverse
set of sequence content and length, have low homology with eukar-
yotic transcripts and span a large range of concentrations. The
amount of observed reads from the six individual samples, which
mapped to known ERCC transcripts, is plotted in Figure 2. The
observed ERCC reads were highly correlated between samples (all
Pearson correlation coefficients . 0.998, all Spearman correlation
coefficients . 0.992). Additionally, each sample correlated strongly
to the known concentrations (all Pearson correlation coefficients .
0.88, all Spearman correlation coefficients . 0.9, see methods for
Figure 1 | Fecal samples were processed to enrich eukaryotic mRNA, develop libraries, and assess bioinformatic sequencing content. The steps in cyan
were applied to mRNA processing and the magenta steps were applied to sequenced read data. Step A, ERCC controls were spiked-in to determine
processing efficacy and reproducibility up to and including step B.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5453 | DOI: 10.1038/srep05453 2
details). Furthermore, using known quantities and concentrations of
exogenous ERCC transcripts, we observed reads frommRNA species
present at amounts as low as 800 molecules in our samples.
We subsequently validated RNA-Seq against qPCR as in15. For this
purpose, eleven differentially-expressed genes, as detected by RNA-
Seq, were selected based on the fact that in the RNA-Seq data set
expression of each gene in all term infants was either higher or lower
than each gene in all preterm infants. In addition, we selected genes
with FPKM greater than 10 since genes expressed at a lower level are
typically difficult to detect by qPCR. Nine of the eleven genes mea-
sured (Figure 3) demonstrated fold-changes of similar magnitude
and direction by qPCR and RNA-Seq (Supplementary Table 2),
while SLC2A1 and RPS16 differed in directionality of differential
expression. By comparison, a similar RNA-Seq validation using
qPCR in the literature observed four out of five DE genes replicated16.
In addition, the average Spearman correlation coefficient between
qPCR and RNA-Seq fold changes calculated was 0.586, and average
Pearson correlation coefficients were 0.570 with an average line of
best fit with slope near unity at 0.869 (Supplementary Figure 2).
To obtain a benchmark for comparison, the average quantified
gene expression for three preterm and three term infants were com-
pared. Overall, global transcriptional profiles compared favorably
with high correlation for highly expressed genes (Figure 4). In addi-
tion, expression correlation between individual samples verified the
presence and detection of human epithelial mRNA transcripts in the
fecal samples (Supplementary Figure 3, Figure 5a). Examples of
genes associated with specific intestinal cell types included absorptive
enterocytes (lactase, 7.4-fold higher expression in preterm than term
and sucrase – isomaltase, 1.7-fold higher expression in term than
preterm), Goblet cells (muc-2, 1.3-fold higher expression in preterm
than term), enteroendocrine cells (chromogranin A, 12-fold higher
expression in term than preterm) and Paneth cells (lysozyme, 1.6-
fold higher expression in preterm than term). In some cases where
small volumes of stool are available, pooling of samples may be
necessary. Therefore, the effect of sequencing pooled samples versus
individual samples from term infants was assessed. Individual sam-
ples and their pooled counterparts exhibited homogeneity as deter-
mined by Spearman correlation coefficients plotted in a heatmap
(Figure 5a). Interestingly, the preterm individuals appeared more
heterogeneous amongst themselves and as compared to the term
samples. This is potentially a result of the larger clinical variation
of the preterm samples in terms of nutrition and gut health. In
addition, when considering genes expressed at an arbitrary cutoff
threshold (.10 Fragments per Kilobase per Million [FPKM]), the
number of genes expressed (Figure 5b) in common among the four
term infant samples (three individual and one pooled) was larger
than the number of genes expressed in common by any subset of
these samples. Therefore, the term individual samples and the pooled
sample were more similar than dissimilar.
Functional gene set enrichment analysis was performed using
Ingenuity Pathway Analysis (IPA) pathway profiling17 to probe the
biological relevance of the differentially expressed genes between
preterm and term infants. For this purpose, differentially expressed
genes with a p value cutoff ,0.05 between groups were associated
with canonical gene networks using the Ingenuity Knowledge base
(Figure 6). Broad differences in genes associated with lipid metabol-
Figure 2 | Observed reads were mapped against known ERCC reference sequences, and read counts were compared against known amounts added in
the spike-in control. High correlations between samples (all Pearson correlation coefficients . 0.998, all Spearman correlation coefficients . 0.992)
and to known concentrations (all Pearson correlation coefficients. 0.88, all Spearman correlation coefficients. 0.9, see methods for details) indicate
that the sequencing and mapping procedures are effective and reproducible across a variety of transcript lengths.
www.nature.com/scientificreports
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ism, molecular transport, organismal injury, infectious disease and
cellular development were observed. This is further highlighted in
Table 1 (preterm . term expression) and Table 2 (term . preterm
gene expression), where differentially-expressed genes associated
with these networks are documented. preterm infants expressed
numerous genes associated with immune cell function (e.g.,
CASP1, IL-1beta, IL-33, NFkB1A, S100-A9, SOCS3, and TREM-1)
and lipid metabolism (e.g., ApoA1, ApoA4, ASAH1, MTM1 and
PLIN2) (Table 1). In contrast, term infants exhibited highly up-
regulated expression of genes associated with regulation of cell
growth/cell cycle (e.g., CDKN2B, ESRRA, INSR, KREMEN2,
MTRNR2L6, PDPK1 and TRIM36) (Table 2).
Discussion
Nutritional regulation of intestinal development begins in uterowith
exposure to protein-rich amniotic fluid and continues after birth
with human milk and/or infant formula1,10. These developmental
processes are essential for continued cellular differentiation of the
gut and development of mucosal immunity18. In the healthy term
infant, the continuumof enteral stimulation is continued postnatally,
whereas the preterm infant is typically supported on parenteral
nutrition with limited enteral stimulation in the first few weeks of
life3. In addition, postnatal exposure to environmental organisms in
the neonatal intensive care unit and the routine use of antibiotics can
lead to aberrant intestinal development, microbial colonization and
risk of intestinal disease in the preterm infant3,6. Hence, it is imper-
ative to understand the transcriptional responses of the preterm gut
so that specific nutritional practices can be employed in order to
optimize intestinal development.
Sensitive noninvasive tests will become critical tools in tailoring
nutritional interventions, including pre- and probiotics, in order to
promote intestinal development and maturation in the growing
infant. As part of this effort, our laboratory has developed a molecu-
lar methodology that utilizes stool samples containing intact
Figure 3 | Eleven differentially expressed genes were selected for validation using qPCR.Nine of the eleven genes exhibited average-fold changes in the
same direction of change as qPCR, with SLC2A1 and RPS16 being the only exceptions. By comparison, a similar RNA-Seq validation using qPCR in the
literature observed four out of five DE genes replicated36. Additionally, correlation analysis (method described in Figure 2 from16) (Supplementary
Table 1 and Supplementary Figure 2) generated average Pearson correlation coefficients of 0.57 and average Spearman correlation coefficients of 0.59with
an average best fit slope line of 0.87.
www.nature.com/scientificreports
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sloughed epithelial cells in order to noninvasively quantify intestinal
gene expression profiles in both the human infant11,12 and adult19.
Systems biology approaches, such as computational linear discrim-
inant analysis (LDA), were used to identify the best single genes and
two- to three-gene combinations for distinguishing term breast-fed
versus formula-fed groups11. In addition, putative ‘‘Master’’ regula-
tory genes were identified using coefficient of determination (CoD)
analysis11. Collectively, these approaches can be used to identify
mechanistic pathways of intestinal development in the first few
months of life, and to assess the impact of nutrition and other envir-
onmental exposures on the microbiome in the developing gut12. In
this study, we have extended upon our initial observations by unra-
veling previously inaccessible complexities in the term vs preterm
infant intestinal transcriptome by non-invasively interrogating the
infant intestine using RNA-Seq, rather than gene microarray11.
In order to develop a more comprehensive understanding of the
complexity of transcriptome profiles in the intestine, we utilized
neonatal stool samples containing intact sloughed epithelial cells
and generated large-scale RNA-Seq genome profiles. For this pur-
pose, poly A1 mRNAs were first copied into DNA sequences, ran-
domly sheared, attached to linkers and directly sequenced. Sequences
were compared with the reference human genome, and the density of
corresponding reads determined. Furthermore, using this form of
global digital transcriptome profiling, we documented the host tran-
script abundance and alternative splicing in healthy term infants at
12-weeks postnatal age and extremely preterm infants (24–30 weeks
gestational age) at 2–5 weeks postpartum. Although the precise ori-
gin of exfoliated cells is not known, results from our previous study11,
and reported herein, indicate that genes associated with discrete
epithelial cell types (absorptive enterocytes, goblet cells, enteroendo-
crine cells, and Paneth cells) are detectable. Thus, it is likely that
transcriptome signatures of both the small and large intestine can
be monitored over time.
The examination of global alterations in gene expression offers
insight into the effects of premature birth and the resultant influence
of environmental exposures uniquely experienced by the preterm
infant (e.g. antibiotics, other medications, prolonged period of par-
enteral nutrition) on intestinal mRNA profiles. RNA-Seq (validated
by qPCR) revealed that following an enrichment process, reads from
stool derived RNA are of human origin. Unlike RNA extracted from
human cell cultures or surgical specimens, where the quality and
quantity of RNA is usually high and RNA degradation can be con-
trolled with tissue handling20, infant stool represents a unique bio-
logical sample. Typically, expressed host transcripts consist of a
narrow stretch of RNA that is rarely longer than several hundred
bp.While exon-exon junctions in principle can be detected, we noted
that less than 5% of transcripts exhibited their splice variants. In this
respect, non-invasive gene expression analysis using infant stool
Figure 5 | (a) Pearson correlation coefficients among normalized mapped read counts (seeMethods for details) for three preterm, three term individuals
and a pooled term sample. Term samples are visibly correlated amongst each other, whereas higher heterogeneity amongst the preterm population is
expected given their differing treatment regimens and developmental stages. A similar correlation heatmap using Spearman correlation coefficients is
shown in Supplementary Figure 6 for completeness. (b) A four-way Venn diagram shows the number of expressed genes (.10 FPKM) among three
individual term samples and a sequenced pooled sample. In the center of the diagram, 2132 genes are expressed in the pooled sample and all three
individuals at greater than 10 FPKM. This large number of shared genes indicates that the sequencing procedure is consistent across sets of samples.
Figure 4 | Expression profiles of reads to mapped human genes show
good between-group correlation on average. This indicates that the
detection of similar expression profiles is likely from the similar tissue
types present in both sets of samples.
www.nature.com/scientificreports
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appears to be more challenging than analysis of formalin fixed, par-
affin embedded (FFPE) tissue21–23. Unlike FFPE tissue blocks that can
yield large quantities of fragmented DNA and RNA sufficient to
explore complete topologies of expressed genes and local properties
of DNA, infant stool requires careful enrichment of human RNA.
Our experience with gene expression in the infant gut indicates that
next generation sequencing provides a robust non-invasive glimpse
into the host transcriptome.We expect that the development of novel
methodologies for library preparation will allow us to further elucid-
ate the physiology of the developing infant intestine.
For obvious reasons, directly examining the host epithelium in the
human preterm infant is unlikely, as intestinal biopsies are not rou-
tinely performed unless medically indicated. Therefore, noninvasive
methodologies currently provide us the best snap shot of infant gene
expression11 and host-microbe dynamic interactions12 in an in vivo
setting. Although future well-controlled studies are needed to evalu-
ate environmental/dietary exposures, this study highlights the poten-
tial of using the described noninvasive technology. We evaluated
genes that were over-expressed in preterm vs. term (Table 1) or term
vs. preterm intestine (Table 2). Although none of the infants were
clinically ill at the time the stool samples were collected, one of the
major categories of genes overexpressed in preterm vs. term samples
was immune function. Because of the vast number of exfoliated
epithelial cells shed from the lining of the intestine on a daily basis,
it is unlikely that changes in cell composition, e.g., contribution of
inflammatory cells from the submucosa, directly contributed to
alterations in gene expression. Several cytokines, including IL1a
and IL-33 were up-regulated in preterm vs. term. In addition, several
genes that regulate the expression of cytokines and other immune
genes were expressed at 3- (NFKB1a) to 6-fold (CASP1) higher levels
in preterm vs. term infant exfoliated cells. Previous studies have
shown that immortalized cells isolated from fetuses (H4 cells) or
tissue explants from fetuses mount a more robust proinflammatory
cytokine response (IL-8) after inflammatory stimulation with lipo-
polysaccharide or IL1b than cells from adult tissue (Caco-2) or
explants from older children24. The excessive inflammatory response
of the immature intestine is in part due to a developmental under-
expression of IkB25 as well as overexpression of the NFkB/MyD88
innate inflammatory genes (TLR2, TLR4, MyD88, TRAF-6, NFkB1
and IL-8) and under-expression of negative regulator genes (SIGIRR,
IRAK-M, A-20 and TOLLIP) in fetal intestine relative to older chil-
dren8. Thus, it appears that activation status of the intestinal innate
immune response may contribute to excessive inflammation in the
immature intestine in response to colonizing bacteria, which is a
hallmark of NEC8.
In exfoliated cells of term infants, up-regulated immune genes
were associated with balancing the immune system, e.g. promoting
T-cell development (LCP2; 3.6-fold greater in term than preterm),
while inhibiting macrophage activation (LENG9; 16-fold greater in
term than preterm). The majority of genes were involved in cell
turnover, by regulating proliferation and apoptosis. One of the most
highly differentially-expressed genes was an anti-apoptotic factor
(MTRNR2L6), which was 5-fold higher in term than preterm.
Another notable gene is SP3 (,2-fold higher in term than preterm),
which is a transcription factor that can be regulated through short-
chain fatty acid - acetylation, potentially supporting the role of these
products ofmicrobialmetabolism in regulating normal gut growth in
term infants26.
In summary, we provide incontrovertible evidence that whole-
genome sequencing of stool-derived RNA can be used to generate
a global transcriptome gene expression signature in neonates. We
have also compared for the first time, the intestinal global transcrip-
tome in individual term and preterm and pooled term infants. Our
findings provide insight into the global patterns of gene expression
that vary in exfoliated epithelial cells of term and preterm infants.We
anticipate that the described noninvasive RNA sequencing-based
Figure 6 | Network enrichment analysis (Ingenuity IPA software) was
performed using differentially expressed genes.Three networks of interest
(a) Lipid metabolism, molecular transport, small molecule biochemistry;
(b) Neurological disease, organismal injury and abnormalities, and
infection disease; and (c) Cellular development, tissue development, lipid
metabolism were generated. Red indicates higher expression in preterm
infants and green indicates higher expression in term infants.
www.nature.com/scientificreports
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approach will enable elucidation of how the bedside clinical man-
agement of an extremely preterm infant population influences intest-
inal gene expression. With this understanding, dietary and medical
practices can be evaluated that optimally promote intestinal develop-
ment and, ideally, identify those clinical practices that approximate
as closely as possible the development of the healthy, term breast fed
infant. The possible uses of non-invasive high-throughput RNA
sequencing data are vast and include early detection (screening),
monitoring disease progression, risk assessment, and diet-dependent
interaction between gutmicrobiota and host epithelium.We propose
that stool samples containing exfoliated cells have the potential for
generating comprehensive, diagnostic gene sets for the noninvasive
identification/prediction of different intestinal phenotypes in
infants.
Methods
Subject recruitment. The experimental human protocol for term infants was
approved by the University of Illinois and Texas A&M Institutional Review Boards
and for preterm infants by the Beth Israel DeaconessMedical Center and Texas A&M
Institutional Review Boards. Informed consent was obtained from parents prior to
participation in the study, and all experiments were performed in accordance with
relevant guidelines and regulations. Details of the study admission criteria and
protocols for term infants have been previously described11. Briefly, healthy, term
exclusively BF or FF infants were eligible for enrollment into the study. All infants
were considered term and gestational age was similar for BF (39.7 6 .08 weeks; range:
38 5/7 to 41 3/7 weeks) and FF (39.7 6 0.4 weeks; range: 38 5/7 to 40 4/7 weeks)
infants. For each term infant, a stool sample was collected at three months-of-age. In
addition, stool samples were collected from six extremely preterm (24–30 weeks
gestation) infants admitted to the Beth Israel Deaconess Medical Center neonatal
intensive care unit (NICU). The six preterm infants had a gestational age ranging
from 24 1/7 weeks of gestation to 30 0/7 weeks. Four infants under 30 weeks
gestational age had a stool sample collected at 4–5 weeks of life, while two preterm
infants at 30 weeks gestational age had a stool sampled at 2 weeks of life. All six
preterm infants were on full enteral feedings (1 formula; 2 breast milk; 3 mixed
formula and breast milk). For full metadata for term and preterm infants, please
consult Supplementary Tables 3 and 4.
Sample preparation and sequencing. PolyA1 RNA was isolated from stool samples
from term and preterm infants as previously described27. ERCCwas diluted 1510 and
0.5 mL was added to each sample. Pooled polyA1 samples from 18 term infants or 6
preterm infants were processed with the NuGEN Ovation 39-DGE kit (San Carlos,
CA) to convert RNA into cDNA followed by NuGEN Encore NGS Library System I
kit to create Illumina libraries, as per manufacturer’s instructions. Sequencing on
Illumina GAIIx and HiSeq 2000 platforms (San Diego, CA) were carried out using
standard Illumina protocols on the Texas A&MUniversity campus. Briefly, 70 ng of
each sample were used to synthesize first and second strand cDNA, which was
purified using Agencourt RNAClean XP beads (Brea, CA) included in the kit. The
cDNA was linearly amplified using the NuGEN SPIA primer, and cDNA quality and
quantity were determined using an Agilent 2100 Bioanalyzer and Nanodrop
spectrophotometer. Three micrograms of cDNA was fragmented using a Covaris S2
sonicator with the following settings: duty cycle 10%, intensity 5, cycles/burst 100,
time 5 min. Fragmented samples were concentrated using the QIAquick PCR
purification kit (Qiagen, Venlo, Netherlands) as per manufacturer’s instructions.
Samples were quantified using the Quant-iT kit (Invitrogen, Carlsbad, CA) and
evaluated for proper fragmentation of 150 to 200 bp on an Agilent Bioanalyzer DNA
1000 chip. Following cDNA fragment repair and purification, Illumina adaptors were
ligated onto fragment ends followed by amplification to produce the final library.
Libraries were quantified using Quant-iT (Invitrogen) and run on an Agilent DNA
Table 1 | Representative differentially expressed genes that were significantly higher in preterm infants versus term infants
Category and
Gene ID
Term (average
FPKM)
Preterm
(average FPKM)
Preterm/
Term
p value
(uncorrected) Description
Lipid Metabolism
ApoA4 483.85 18651.40 38.55 0.0001 Lipid metabolism, chylomicron and VLDL secretion
ApoA1 254.23 6906.41 27.17 0.0001 Lipid metabolism, reverse cholesterol transport
ASAH1 14.90 80.51 5.40 0.0064 Acid ceramidase, mediates cell growth arrest, differentiation and apoptosis
CERS2 92.13 371.37 4.03 0.0061 Ceramide synthase 2, regulates cell growth
MTM1 3.10 59.97 19.36 0.0037 Lipid phosphatase that negatively regulates EGFR degradation
PLIN2 127.72 359.13 2.81 0.0149 Controls the levels of lipid droplets, regulation of colonic cell growth
Immune
CASP1 128.56 888.21 6.91 0.0030 Inflammasomes mediate activation of caspase 1 and promote secretion of
IL-1beta and IL-18
IL1B 2343.32 6974.19 2.98 0.0926 Linked to intestinal disorders of inflammation in neonates
ICAM1 34.94 112.40 3.22 0.0280 Leukocyte trafficking across the endothelium
IL33 10.52 61.12 5.81 0.0144 Innate immune cell modulation, mediates Th2 immune response (parasite
infections)
LCP1 14.06 72.14 5.13 0.0081 Associated with active Crohn’s disease
NFKBIA 373.98 1164.21 3.11 0.0112 Regulates many epithelial and immune cell functions
PFKFB3 237.61 621.85 2.62 0.0271 Gene target of PPARgamma, regulates diet induced intestine inflammation
response
S100-A9 71.14 1192.90 16.77 0.0043 Calcium and zinc binding protein that regulates inflammatory and immune
responses; functions extracellularly as an antimicrobial
SOCS3 164.05 748.63 4.56 0.0017 Suppressor of cytokine signaling, generally anti-inflammatory that limits IL-6
induction of STAT3
TREM-1 15.29 96.78 6.33 0.0172 Expressed on myeloid cells (PMNs, monocytes/macrophages), increases
with inflammatory diseases, linked to macrophage amplification of
chronic inflammation
TYROBP 153.23 902.38 5.89 0.0067 An adaptor protein associated with multiple cell surface activating receptors
expressed on both lymphoid and myeloid lineages
Cellular Function
CEBPB 75.39 290.56 3.85 0.0098 Transcription factor regulating keratin synthesis
CFLAR 30.29 139.71 4.61 0.0451 Apoptosis regulatory protein, tissue homeostasis
FAM65B 9.00 169.30 18.81 0.0007 Promotes myogenic differentiation and cytoskeletal rearrangement
FUBP1 31.78 110.84 3.49 0.0128 DNA binding protein that promotes c-myc expression
G0S2 2927.30 60194.00 20.56 0.0003 Promotes apoptosis, prevents bcl2-bax heterodimers
KDM5B 32.12 98.30 3.06 0.0281 Histone demethylase, favors cell proliferation
MMP1 53.25 159.15 2.99 0.0392 Matrix metalloproteinase, potential regulator of intestinal homeostasis
NPM1 59.07 165.49 2.80 0.0484 Nucleolar acidic protein, plays a positive role in cell proliferation and growth
SERPINA1 136.74 534.73 3.91 0.0012 Serine protease inhibitor, proteolytic activity towards insulin, protects lower
respiratory tract
www.nature.com/scientificreports
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Chip 1000 to confirm appropriate sizing and the exclusion of adapter dimers.
Approximately 32 million, 36 bp reads were sequenced in each lane for the pooled
samples on an Illumina GAIIx [SRA:SRR626229] and approximately 300 million,
50 bp single end reads on an Illumina HiSeq for the six individual samples
[SRA:PRJNA182262]. Pooled and individual sample collection and processing is
depicted visually in Supplementary Figure 4. Raw, de-multiplexed FASTQ files were
examined using FastQC and determined to be of sufficient read quality, and sequence,
nucleotide, and k-mer diversity. The number of ERCC molecules present in the
samples was calculated using known concentrations of ERCC transcripts as published
by Ambion and the quantity of RNA solution that was used for library preparation.
Next generation sequencing read alignment. A wide array of reference genomes
were assembled to identify the rough composition of detected RNA reads (see
Supplementary Methods). The UCSC hg19 human reference genome was used with
annotation from the Illumina iGenomes resource28. Microbial, mitochondrial, fungal,
viral, and protozoan nucleotide databases were obtained from RefSeq version 59
which resulted in 18.5 Gb, 100 Mb, 2.3 Gb, and 1.7 Gb genomes, respectively.
580 Mb of ribosomal sequences were obtained from SILVA release 11129, using both
small and large subunit repositories. BWA30 was used to align reads against the
bacterial reference genome due to its size. SNAP31 was used to align tomitochondrial,
ribosomal, and viral references, and STAR32 was used for protozoan, fungal, human,
and ERCC reference genomes due to the possible presence of splice junctions. All
alignment was performed using default tolerance parameters and considered
acceptable based on the agreement with known and observed ERCC controls.We also
compared our alignments against the slower TopHat aligner33 and obtained similar
results. Readmapping results were visualized in Integrative Genomics Viewer, IGV34.
Additional details regarding reference genomes and automated source code for
analysis are available in the Supplementary Materials.
Gene expression quantification. As a genome-guided assembly method, Cufflinks
was used to estimate gene expression for the human reference and HTSeq was used
for all other references35,36. Due to the 39 selection based enrichment and subsequent
observed 39 bias in read alignment, normalized read counts for expression correlation
results were also used. Read counts were obtained usingHTSeq and normalized by the
mean expression of 3804 ‘‘house-keeping’’ mRNA species as determined by37.
Correlation of ERCC measurements between samples and known concentrations
were performed following log transformation and addition of 0.001 to the counts to
avoid unbounded values. This was utilized for the Spearman correlation coefficient
because of the logarithmic nature of the concentrations provided in ERCC spike-in
kits. Differential expression testing was performed using Cuffdiff as available from the
Cufflinks package. Genes with P-values , 0.05 were input into the Ingenuity IPA
analysis tools (Ingenuity Systems Inc., Redwood City, CA) to assess pathway,
biological function, and upstream activity14 and are visualized in a volcano plot in
Supplementary Figure 5 as produced by the cummeRbund package.
Real time PCRwas used for gene expression confirmation. For this purpose, cDNA
was prepared from fecal RNA from three term and three preterm infants using
SuperScript II (LifeTechnologies, Carlsbad, CA) followed by PCR on an ABI 7900HT
Real Time PCR System. TaqMan assays were purchased for ABCC5, APOA4, CASP1,
DYNLL1, NFKBIA, PLIN2, PPAP2A, RPS16, SCNN1A, SLC2A1, and TMSB4X
(LifeTechnologies). These genes were selected from a larger set of differentially
expressed genes in term vs. preterm infants as identified in the IPA analysis.
Ingenuity pathway analyses. ‘‘Functional enrichment’’ analysis was performed using
Ingenuity Pathway Analysis (IPA) version 2.0 software. To perform IPA analysis, all
differentially expressed genes (P, 0.05) in the preterm or term infants were uploaded
into three columns for the purpose of generating Illumina probe ID, t-value (fold
change) and P-value data. P-values were uncorrected formultiple testing owing to the
number of human fecal samples. By default, during IPA analysis, onlymolecules from
the data set associated with the Ingenuity Knowledge Base repository (Ingenuity
Systems Inc.) were considered. Functional Analysis identified the biological functions
and/or diseases that were most significant to the data set. The significance of the
association between the data set and the specific pathways of interest was determined
in three ways: (a) as a ratio of the number of molecules from the data set that mapped
to the pathway divided by the total number ofmolecules thatmapped to the Ingenuity
Knowledge Base pathway, (b) Fisher’s exact test was used to calculate a P value
determining the probability that the association between the genes in the data set and
the pathway of interest could be explained by chance alone, and (c) activation state
(‘‘increased’’ or ‘‘decreased’’) was inferred by the activation z-score. The derivations of
the z-scores are based on relationships in the molecular network that represent
experimentally observed causal associations between genes and those functions.
‘‘Canonical pathway’’ analysis was used to identify networks from the IPA library
that were most significantly modulated across subject groups. Significance of the
association between each data set and the canonical pathway wasmeasured in 2 ways:
(1) as a ratio of the number ofmolecules from the data set thatmapped to the pathway
Table 2 | Representative differentially expressed genes that were significantly higher in term versus preterm infants
Category and
Gene ID
Term (average
FPKM)
Preterm
(average FPKM)
Term/
Preterm
p value
(uncorrected) Description
Immune
CD177 197.49 19.186 10.29 0.01215 A glycosylphosphatidylinositol (GPI)-anchored membrane protein is a
potential receptor for PR3, the preferred target of antineutrophil cytoplasmic
antibodies (ANCAs) in Wegener’s granulomatosis. Involved in neutrophil
transmigration.
IFI27 4643.67 1503.71 3.09 0.0256 Mediates IFN-induced apoptosis
IRF9 293.777 45.0231 6.53 0.0048 Transcription regulatory factor that mediates type I interferons
LENG9 1209.33 73.0508 16.55 0.00145 Negative regulators of macrophage activation
LCP2 86.2228 24.4284 3.53 0.0378 SLP76, a substrate for T cell ZAP70, promotes T cell development
Cellular Function
ABCC5 122.498 20.6639 5.93 0.00545 ATP binding cassette transporter
ATP5B 162.509 41.1475 3.95 0.01605 ATP synthase
BNIP2 44.0329 7.76199 5.67 0.0191 bcl-2 binding protein, responsive to estrogen; regulates cell dynamics by
interacting with cdc42
CDKN2B 243.227 86.5265 2.81 0.02475 Cyclin dependent kinase inhibitor, controls cell cycle G1 progression
DYNLL1 528.599 129.298 4.09 0.01345 Intracellular transport and motility
ESRRA 435.007 83.0017 5.24 0.01245 Estrogen receptor related alpha, cell growth and maintenance
INSR 49.2393 14.5811 3.38 0.00755 Insulin receptor, regulates cell growth
KREMEN2 63.2595 0 NA 0.0284 Receptor for Dickkopf protein, cooperates with Dickkopf to block Wnt
signaling.
MLLT4 53.2364 14.4052 3.70 0.0059 Organization of cell junctions, belongs to the cell adhesion system
MTRNR2L6 340.597 36.8941 9.23 0.00025 Antiapoptotic factor
PDPK1 54.8395 9.62117 5.70 0.0045 Master lipid kinase regulating PI-3 kinase pathway/Akt, apical endosome
trafficking
RAP2A 81.8369 29.7633 2.75 0.0357 Belongs to the ras oncogene family, regulates cytoskeletal rearrangements
SCNN1A 132.419 16.8286 7.87 0.0077 Sodium mediated non voltage ion channel. Mediates diffusion of luminal
sodium and water through the apical membrane
SP3 56.516 21.7481 2.60 0.0271 A transcription factor that can be regulated by acetylation, e.g., SCFA, can
repress insulin like growth factor action.
TRIM36 50.8464 5.88888 8.63 0.0004 Mediates ubiquitination and proteosomal degradation; chromosome
segregation and cell cycle regulation
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divided by the total number of molecules that mapped to the canonical pathway, and
(2) Fisher’s exact test was used to calculate p-values determining the probability that
the association between genes in the dataset and each canonical pathway was
explained by chance alone.
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